Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Choiceone Financial
COFS
$509M
| $389K | ﹤0.01% |
16,900
+1,200
| +8% | +$27.8K |
|
3002
Immunic
IMUX
$190M
| $389K | ﹤0.01% |
15,490
-22,256
| -59% | -$373K |
|
|
RVLP
3003
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $389K | ﹤0.01% |
694,915
-2,500
| -0.4% | -$2.21K |
|
3004
Carrier Global
CARR
$51B
| $388K | ﹤0.01% |
7,805
-1,567,626
| -100% | -$69M |
|
3005
Vanguard Russell 1000 Value ETF
VONV
$20.7B
| $388K | ﹤0.01% |
5,600
-1,900
| -25% | -$128K |
|
3006
GEE Group
JOB
$23.1M
| $387K | ﹤0.01% |
755,200
-545,800
| -42% | -$264K |
|
|
AKTS
3007
DELISTED
Akoustis Technologies Inc
AKTS
| $385K | ﹤0.01% |
121,000
-54,129
| -31% | -$166K |
|
3008
Optical Cable Corp
OCC
$131M
| $384K | ﹤0.01% |
95,003
-1,000
| -1% | -$4.21K |
|
|
THRX
3009
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $384K | ﹤0.01% |
41,200
-89,400
| -68% | -$881K |
|
|
CFMS
3010
DELISTED
Conformis, Inc. Common Stock
CFMS
| $384K | ﹤0.01% |
175,302
+6,600
| +4% | +$9.38K |
|
3011
Capital Group Growth ETF
CGGR
$23.8B
| $383K | ﹤0.01% |
15,200
+1,300
| +9% | +$30.3K |
|
|
STRM
3012
DELISTED
Streamline Health Solutions
STRM
| $383K | ﹤0.01% |
20,125
+1,340
| +7% | +$32.3K |
|
3013
Enviri
NVRI
$623M
| $382K | ﹤0.01% |
+38,734
| New | +$319K |
|
3014
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.49B
| $382K | ﹤0.01% |
+13,000
| New | +$355K |
|
3015
Business First Bancshares
BFST
$1.04B
| $381K | ﹤0.01% |
25,300
+3,200
| +14% | +$49.3K |
|
3016
Teledyne Technologies
TDY
$30.4B
| $381K | ﹤0.01% |
+927
| New | +$382K |
|
|
WIMI
3017
WiMi Hologram Cloud
WIMI
$22.1M
| $380K | ﹤0.01% |
34,590
+860
| +3% | +$8.72K |
|
|
ALIM
3018
DELISTED
Alimera Sciences
ALIM
| $379K | ﹤0.01% |
129,716
+28,322
| +28% | +$65K |
|
3019
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.77B
| $378K | ﹤0.01% |
11,000
+1,500
| +16% | +$48.9K |
|
|
CLSD
3020
DELISTED
Clearside Biomedical
CLSD
| $377K | ﹤0.01% |
22,446
-8,180
| -27% | -$141K |
|
3021
Global Indemnity Group
GBLI
$402M
| $377K | ﹤0.01% |
11,214
+3,000
| +37% | +$87.7K |
|
3022
Ovid Therapeutics
OVID
$414M
| $376K | ﹤0.01% |
114,700
-5,900
| -5% | -$20K |
|
3023
LiveOne
LVO
$61.7M
| $373K | ﹤0.01% |
21,170
+8,530
| +67% | +$120K |
|
|
YI
3024
111 Inc
YI
$33.9M
| $372K | ﹤0.01% |
15,135
+4,000
| +36% | +$107K |
|
3025
Dimensional US Targeted Value ETF
DFAT
$14.6B
| $371K | ﹤0.01% |
+8,000
| New | +$351K |
|
Similar funds
Renaissance Technologies's Q2 2023 Portfolio in Review
As of Q2 2023, Renaissance Technologies held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Berkshire Hathaway Class A worth $316M.
- Renaissance Technologies's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Renaissance Technologies added most to Apple in Q2 2023, an estimated $856M increase.
- Renaissance Technologies's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Renaissance Technologies fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Renaissance Technologies's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Renaissance Technologies opened 542 new positions and closed 599 in Q2 2023.
- Renaissance Technologies's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.